A Comprehensive Pharmacological and Clinical Monograph of Povidone-Iodine (DB06812)

Executive Summary

Povidone-iodine (PVP-I), identified by DrugBank ID DB06812, is a cornerstone of modern antisepsis. It exists as a stable chemical complex of elemental iodine with the polymer polyvinylpyrrolidone (PVP), a formulation designed to overcome the significant limitations of historical iodine tinctures. This monograph provides an exhaustive analysis of its chemical properties, historical context, pharmacological profile, clinical utility, and safety considerations. The development of PVP-I in 1955 marked a pivotal advancement, creating an "iodophor" that acts as a reservoir, providing sustained release of free iodine. This mechanism confers a broad-spectrum microbicidal activity against bacteria (including antibiotic-resistant strains), viruses, fungi, and protozoa, while significantly reducing the local irritation and systemic toxicity associated with elemental iodine solutions.

The mechanism of action is multifactorial, involving the rapid penetration of microbial cells by free iodine, followed by the denaturation of essential proteins, oxidation of cellular lipids, and disruption of nucleic acids. This multi-pronged attack makes the development of microbial resistance exceedingly rare. Clinically, PVP-I is utilized across a vast range of applications, from pre- and post-operative skin disinfection and surgical hand scrubbing to first aid for minor wounds, management of chronic ulcers, ophthalmic prophylaxis, and oropharyngeal decontamination. It is available in numerous formulations, including solutions, scrubs, ointments, powders, and specialized preparations for vaginal and ocular use, with concentrations tailored to specific applications.

Despite its widespread use and generally favorable safety profile, a critical understanding of its pharmacokinetics and potential for toxicity is essential. Contrary to simplified summaries suggesting it is not absorbed, significant evidence demonstrates that iodine from PVP-I can be systemically absorbed, particularly when applied to large wounds, burns, or mucosal surfaces. This absorption can lead to clinically significant adverse effects, including renal impairment, metabolic acidosis, and thyroid dysfunction, necessitating cautious use in at-risk populations such as neonates, pregnant women, and patients with pre-existing renal or thyroid disorders. Furthermore, the common patient-reported "iodine allergy" is frequently a misinterpretation of irritant contact dermatitis or an unrelated allergy, and rarely a true hypersensitivity to PVP-I itself; this distinction is crucial for appropriate clinical decision-making.

In comparative analyses, particularly for the prevention of surgical site infections (SSIs), alcohol-based chlorhexidine preparations have demonstrated superior efficacy in many clinical trials, primarily due to faster onset and a more persistent residual antimicrobial effect. Nonetheless, povidone-iodine remains an indispensable agent, especially for applications on mucous membranes, in ophthalmology, and in cases of chlorhexidine hypersensitivity. Its ongoing review by regulatory bodies like the U.S. FDA underscores the continuous evolution of standards for antiseptic agents. This report synthesizes the available evidence to provide a nuanced, comprehensive resource for healthcare professionals, guiding the safe and effective use of this historically significant and clinically vital medication.

Chemical Identity and Physicochemical Profile

Povidone-iodine is a well-characterized small molecule antiseptic agent that is chemically defined as a complex of a polymer and elemental iodine.[1] A thorough understanding of its chemical and physical properties is fundamental to appreciating its formulation, stability, mechanism of action, and therapeutic advantages over older iodine-based antiseptics.

The agent is cataloged under several international identifiers, ensuring its unambiguous recognition in scientific and regulatory databases. These include DrugBank ID DB06812, CAS (Chemical Abstracts Service) Number 25655-41-8, PubChem CID 410087, and UNII 85H0HZU99M.[1] It is known by various synonyms, the most common being iodopovidone, polyvidone iodine, povidone, iodinated, and the widely used abbreviation PVP-I.[1] The formal IUPAC (International Union of Pure and Applied Chemistry) name is given as 1-ethenyl-2-pyrrolidinone, homopolymer, compound with iodine, or more simply, 1-ethenylpyrrolidin-2-one; diiodine, which describes the two core components: the povidone polymer and diatomic iodine.[1]

The molecular structure is that of a complex, not a simple mixture. The formula is often represented as (C6​H9​NO)n​⋅xI or (C6​H9​NO)n​I2​, reflecting that it is a homopolymer of N-vinyl-2-pyrrolidinone (povidone or PVP) complexed with a variable amount of iodine.[3] For the monomeric unit of povidone complexed with diatomic iodine, the molecular formula is cited as

C6​H9​I2​NO with a corresponding molecular weight of approximately 364.95 g/mol.[5] However, as a polymer, the total molecular weight of the complex is variable.

A defining characteristic of povidone-iodine is that it is an "iodophor," a substance containing iodine complexed with a solubilizing agent, which in this case is the povidone polymer.[8] This complex contains from 9.0% to 12.0% available iodine, calculated on a dry basis, which is the therapeutically active component.[2] Physically, povidone-iodine appears as a yellow-brown to red-brown amorphous or crystalline powder.[7]

Its solubility profile is a key aspect of its utility. It is soluble in cold and mild-warm water, as well as in various alcohols and glycols including ethyl alcohol, isopropyl alcohol, polyethylene glycol, and glycerol.[1] Conversely, it is insoluble in nonpolar organic solvents such as ether and chloroform.[1] This aqueous solubility is a significant advantage over elemental iodine. Furthermore, the stability of povidone-iodine in solution is markedly greater than that of traditional iodine preparations like tincture of iodine or Lugol's solution.[1] For optimal preservation, it should be stored in airtight containers in a cool, dry, and well-ventilated area.[7]

The very nature of povidone-iodine as a chemical complex is the key to its pharmacological profile and its superiority over its predecessors. Early iodine antiseptics were simple solutions that delivered a high concentration of free iodine directly to tissues, leading to significant irritation, pain, and toxicity.[1] The innovation of povidone-iodine was to bind iodine (in the form of triiodide,

I3−​) to the large polyvinylpyrrolidone polymer.[1] This binding creates a reservoir. The complex itself is not the primary microbicidal agent; its function is to act as a carrier that slowly releases free iodine into the surrounding solution.[1] This slow-release mechanism ensures that the concentration of free, active iodine in contact with mammalian cells at any given moment is minimized, which directly accounts for its improved tolerability and reduced toxicity.[1] Concurrently, this sustained release from the polymer backbone provides a longer-lasting antiseptic effect compared to the rapid action and evaporation of tinctures, making it a preferred agent for lengthy surgical procedures.[1] Therefore, the term "complex" is not merely a chemical descriptor but the central principle explaining its enhanced therapeutic index.

Property	Value / Description	Source(s)
DrugBank ID	DB06812	1
Type	Small Molecule	1
CAS Number	25655-41-8	1
Synonyms	Iodopovidone, Polyvidone iodine, PVP-I	1
IUPAC Name	1-ethenyl-2-pyrrolidinone, homopolymer, compd. with iodine	1
Molecular Formula	(C6​H9​NO)n​⋅xI (Polymer complex)	4
Molecular Weight	~364.95 g/mol (for monomeric complex)	5
Appearance	Red-brown crystalline or amorphous powder	7
Solubility	Soluble in water, ethanol, isopropanol, glycerol; Insoluble in ether, chloroform	1
Stability	More stable in solution than iodine tinctures; store in cool, dry, airtight containers	1
Composition	Complex of polyvinylpyrrolidone (PVP) and iodine	1
Available Iodine	9.0% to 12.0% (calculated on a dry basis)	2
pH (Solution)	1.5 - 5.0	7

Historical Development and Evolution of an Iodophor

The development of povidone-iodine is a landmark in the history of antiseptics, representing a deliberate and successful effort to harness the potent microbicidal power of iodine while mitigating its inherent drawbacks. The story begins with the discovery of the element iodine in 1811 by French chemist Bernard Courtois.[1] Its powerful antiseptic properties were quickly recognized, and by 1839, iodine preparations were being used for the treatment of wounds.[11] Throughout the 19th and early 20th centuries, iodine became a mainstay of infection control, valued for its effective, broad-spectrum activity against bacteria, fungi, viruses, and protozoa.[1]

However, these early preparations, typically aqueous solutions or alcoholic tinctures, were far from ideal. Their clinical use was plagued by significant limitations, including severe pain and irritation at the site of application, potential for systemic toxicity upon absorption, and the characteristic dark staining of skin and fabrics.[1] These drawbacks created a clear clinical need for a new formulation that could deliver iodine's benefits without its associated harms.

This need was met in 1955 with a breakthrough discovery by H. A. Shelanski and M. V. Shelanski at the Industrial Toxicology Laboratories in Philadelphia.[2] They successfully created a stable chemical complex of elemental iodine with the synthetic polymer polyvinylpyrrolidone (PVP). This new entity, povidone-iodine, was the first commercially successful "iodophor"—a carrier molecule that binds iodine and releases it slowly.

The initial research by the Shelanskis was compelling. In vitro tests demonstrated potent antibacterial activity, while studies in mice revealed that the complex was significantly less toxic than the traditional tincture of iodine.[7] Subsequent human clinical trials confirmed these findings, showing the povidone-iodine complex to be superior to other existing iodine formulations in both efficacy and tolerability.[7]

The impact was immediate and profound. Povidone-iodine was brought to market shortly after its discovery and quickly became the "universally preferred iodine antiseptic," supplanting the older, harsher tinctures in hospitals and clinics worldwide.[2] Its importance to global public health is underscored by its inclusion on the World Health Organization's List of Essential Medicines, a curated list of the most effective and safe medicines needed in a basic health system.[1] The development of povidone-iodine thus stands as a classic example of pharmaceutical innovation, where the principles of chemistry were applied to solve a long-standing clinical problem, resulting in a safer, more effective, and more versatile therapeutic agent.

Mechanism of Action and Pharmacodynamics

The pharmacological activity of povidone-iodine is a direct consequence of its unique structure as an iodophor complex. Its mechanism of action is multifaceted, combining the potent, non-specific microbicidal effects of elemental iodine with a sophisticated delivery system that enhances efficacy and safety.

The Iodophor Complex: Carrier and Reservoir

Povidone-iodine is fundamentally an "iodophor," a term signifying that the povidone (polyvinylpyrrolidone or PVP) polymer acts as a carrier and solubilizing agent for iodine.[9] The PVP component itself possesses no intrinsic microbicidal activity; its role is purely that of a vehicle.[17] The complex holds iodine in a stable reservoir, from which a small but effective amount of "free iodine" (

I2​) is slowly and continuously liberated into the surrounding solution upon application.[1]

This dynamic equilibrium between the bound and free forms of iodine is the cornerstone of povidone-iodine's therapeutic profile. The slow, sustained release of the active moiety ensures a prolonged antiseptic effect, which is particularly advantageous for long surgical procedures.[1] Simultaneously, this controlled release minimizes the peak concentration of free iodine in contact with mammalian tissues, thereby reducing the local irritation, stinging, and systemic toxicity that characterized older iodine tinctures.[1]

Multi-Modal Antimicrobial Action of Free Iodine

Once liberated from the PVP complex, free iodine exerts a rapid and lethal effect on microorganisms through a multi-pronged attack on fundamental cellular structures and processes. This non-specific, multi-target mechanism is a key reason why the development of microbial resistance to povidone-iodine is virtually nonexistent.[13]

The primary steps of its action are as follows:

1. Rapid Penetration: As a small molecule, free iodine quickly penetrates the cell walls of microorganisms, including bacteria, fungi, and viruses.[9]
2. Protein Disruption: Iodine aggressively targets proteins, causing their denaturation and precipitation. It achieves this by reacting with key amino acids, particularly the sulfhydryl (-SH) groups of cysteine and the aromatic rings of tyrosine and histidine. This action inactivates critical structural proteins and enzymes essential for microbial survival.[9]
3. Cell Membrane Damage: Iodine attacks the microbial cell membrane by iodinating lipids and oxidizing the double bonds in unsaturated fatty acids. This disrupts the integrity of the lipid bilayer, leading to increased permeability, leakage of essential cellular contents, and ultimately, cell lysis.[1]
4. Nucleic Acid Interference: The oxidative power of iodine extends to nucleic acids. It interacts with and oxidizes nucleotides within the microbial DNA and RNA, which can lead to mutations, strand breaks, and inhibition of replication and protein synthesis, culminating in cell death.[9]
5. Metabolic Disruption: Free iodine disrupts vital metabolic pathways by targeting and deactivating cytosolic enzymes, particularly those involved in the respiratory chain. This leads to a catastrophic failure of cellular energy production.[9]

Broad Antimicrobial Spectrum

The result of this multi-modal attack is an exceptionally broad spectrum of antimicrobial activity. Povidone-iodine is effective against virtually all types of clinically relevant pathogens [1]:

• Bacteria: It is bactericidal against both Gram-positive and Gram-negative bacteria.
• Resistant Pathogens: It is notably effective against antibiotic-resistant strains of significant clinical concern, such as Methicillin-resistant Staphylococcus aureus (MRSA), and has demonstrated activity against strains that have developed resistance to other antiseptics like chlorhexidine.[11]
• Viruses: It has potent virucidal activity against a wide range of viruses, including both enveloped (e.g., HIV, Herpes Simplex, Influenza, Ebola, Coronaviruses) and non-enveloped viruses.[1] Its efficacy against SARS-CoV, MERS-CoV, and SARS-CoV-2 has been demonstrated in vitro, prompting clinical investigation during the COVID-19 pandemic.[15]
• Fungi and Protozoa: It is fungicidal and effective against various protozoans.
• Spores: It is sporicidal, although this action typically requires longer contact times compared to its effect on vegetative bacteria.

Pharmacodynamic Factors and Anti-Inflammatory Effects

Several factors influence the pharmacodynamic activity of povidone-iodine in a clinical setting. One of the most important and counterintuitive is the "dilution paradox." While one might assume that the standard 7.5-10% commercial solutions are the most potent, this is not the case for immediate bactericidal activity.[1] The concentration of free, active iodine is governed by the equilibrium

PVP-I Complex <=> PVP + Free Iodine. As the solution is diluted with water, this equilibrium shifts to the right, causing the polymer to release a higher proportion of its bound iodine.[11] This results in a paradoxical increase in the concentration of the active microbicidal agent, leading to more rapid killing action. This effect reaches its peak at dilutions of approximately 1:100 (a 0.1% strength solution), after which further dilution decreases the absolute amount of available iodine.[9] This principle explains why lower concentrations (e.g., 0.5% to 2.5%) are highly effective for sensitive applications like ophthalmic solutions and mouth rinses, challenging the simple assumption that "stronger is better".[1]

Another critical factor is the presence of organic matter. The efficacy of povidone-iodine is significantly reduced by organic materials such as blood, pus, serum, and feces.[11] These substances contain proteins and other molecules that can react with and neutralize the free iodine, rendering it inactive. This pharmacodynamic limitation highlights the clinical importance of physically cleaning a wound or surgical site to remove gross contamination before applying the antiseptic.

Finally, beyond its direct microbicidal effects, in vitro evidence suggests that povidone-iodine may also beneficially modulate the host's inflammatory response. It has been shown to inhibit the release of inflammatory mediators like Tumor Necrosis Factor-alpha (TNF-α), inhibit the action of tissue-degrading metalloproteinases, and potentiate healing signals by activating key immune cells, including monocytes, T-lymphocytes, and macrophages.[9] These potential anti-inflammatory properties may contribute to its overall utility in wound management.

Pharmacokinetics: A Critical Analysis of Systemic Absorption

The pharmacokinetic profile of povidone-iodine is a subject of significant nuance and is often oversimplified in standard drug summaries. A critical analysis of the available evidence reveals that the extent of its systemic absorption is highly dependent on the clinical context of its use, a reality that has profound implications for its safety profile.

The Absorption Controversy: A Re-evaluation of "Topical Use Only"

Standard pharmacological databases, such as DrugBank, present a simplified pharmacokinetic profile for povidone-iodine, repeatedly stating that it is "intended for topical application and is not absorbed".[9] This characterization is common for drugs intended for local action where systemic effects are not expected under normal use conditions.

However, this statement stands in stark contrast to a substantial body of evidence from clinical case reports, dedicated research studies, and in vitro experiments. This evidence overwhelmingly demonstrates that iodine from povidone-iodine preparations is systemically absorbed, and the degree of absorption can be clinically significant. The key determinant of absorption is the integrity of the epidermal barrier. While absorption through intact skin is limited, it is markedly increased when the barrier is compromised.

Factors that significantly influence and increase systemic absorption include:

• Application Site: Absorption is highest from mucosal surfaces (e.g., vaginal, peritoneal) and lowest from intact skin, with application to wounds and burns falling in between.[21]
• Barrier Integrity: The presence of broken skin, such as in wounds, ulcers, or burns, dramatically increases the rate and extent of transdermal iodine absorption.[1]
• Surface Area of Application: The larger the area of the body to which povidone-iodine is applied, the greater the total amount of iodine that can be absorbed.[21] This is particularly relevant in the treatment of patients with extensive burns.[25]
• Duration and Frequency of Use: Prolonged or repeated application, such as continuous irrigation or frequent surgical hand scrubbing by healthcare professionals, can lead to cumulative absorption.[20] In vitro studies using Franz diffusion cells have confirmed that iodine can permeate even intact human skin in a time-dependent manner, with a lag time of approximately 9 hours before significant permeation is detected.[28]

The most accurate understanding reconciles these conflicting data points: for its primary over-the-counter indication on minor cuts and scrapes on a small area of otherwise healthy skin, systemic absorption is minimal and generally considered clinically negligible. However, for many hospital-based and off-label uses—such as irrigation of the mediastinum or peritoneal cavity, treatment of large-surface-area burns, or prolonged application to mucosal surfaces—systemic absorption is a critical and undeniable pharmacokinetic event that directly informs the drug's safety profile and potential for toxicity.[20]

Systemic Distribution, Metabolism, and Excretion

Once iodine is systemically absorbed from a povidone-iodine preparation, it enters the body's iodide pool and follows the established pharmacokinetics of the element.[21]

• Distribution: Absorbed iodine has an approximate volume of distribution of 23 liters. A key feature of its distribution is active uptake and concentration by the thyroid gland, which uses it for hormone synthesis. It is also taken up by other tissues, including salivary glands and breast tissue.[21]
• Metabolism: In the body, absorbed elemental iodine is rapidly converted into iodide (I−), which is the form utilized by the thyroid and other tissues.[21]
• Excretion: The primary route of elimination for absorbed iodide is renal. Approximately 97% of a systemic dose is excreted via the kidneys. The biological half-life of this systemically circulating iodide is approximately 2 days.[21] The half-life of iodine that has been incorporated into the thyroid gland is much longer, at about 7 weeks.[21]

Specialized Pharmacokinetics: The Ocular Compartment

Specific pharmacokinetic data is available for the use of povidone-iodine within the eye, derived from studies involving intravitreal injections in rabbit models. This is a specialized context distinct from topical skin application. In the vitreous humor, povidone-iodine exhibits dose-dependent, non-linear elimination that is best described by Michaelis-Menten kinetics.[29] The terminal half-life (

t1/2​) of povidone-iodine in the vitreous is short, measured to be approximately 3 hours (ranging from 3.27 to 3.58 hours).[30] This rapid clearance from the ocular compartment has important clinical implications. It suggests that a single intravitreal injection may be insufficient to maintain therapeutic concentrations for treating an established infection like endophthalmitis. Consequently, a strategy of repeated, low-concentration injections may be a more effective therapeutic approach.[30]

Parameter	Clinical Context	Value / Description	Source(s)
Absorption	Intact Skin (minor use)	Generally considered clinically negligible.	9
	Intact Skin (repeated, large area)	Possible with prolonged/frequent use (e.g., surgical scrubs). Lag time of ~9 hours.	28
	Broken Skin (wounds, burns)	Significant systemic absorption occurs; rate depends on surface area and severity.	1
	Mucosal Surfaces	High potential for rapid and significant systemic absorption.	21
Distribution	Systemic (post-absorption)	Volume of distribution ~23 L. Active uptake into the thyroid gland.	21
Metabolism	Systemic (post-absorption)	Rapidly converted to iodide (I−) in the body.	21
Half-life (t1/2​)	Systemic (post-absorption)	Biological half-life of absorbed iodide is ~2 days.	21
	Intravitreal Compartment	Terminal half-life is ~3 hours.	30
Elimination	Systemic (post-absorption)	Primarily renal; ~97% of absorbed iodine is excreted via the kidneys.	21

Clinical Applications and Evidence-Based Use

Povidone-iodine's broad antimicrobial spectrum, favorable tolerability compared to older iodine preparations, and versatility in formulation have led to its widespread use in a vast array of clinical settings. Its applications range from routine surgical antisepsis to specialized uses in ophthalmology, gynecology, and wound care.

Surgical Antisepsis

This remains one of the most common and critical applications of povidone-iodine.

• Pre-operative Skin Preparation: Povidone-iodine is widely used to disinfect the patient's skin at the surgical site immediately before an incision. This application aims to rapidly reduce the microbial load on the skin, thereby minimizing the risk of endogenous pathogens causing a surgical site infection (SSI).[1] Formulations for this purpose typically include 10% solutions (e.g., Betadine Solution) and 7.5% or 10% surgical scrubs, which contain detergents to aid in cleaning.[1]
• Surgical Hand Scrub: It is also a standard agent for the disinfection of the hands and forearms of surgeons and other healthcare providers before performing surgical procedures.[1]

Wound Management

Povidone-iodine is extensively used for both acute and chronic wound care.

• First Aid: As an over-the-counter product, it is indicated for the treatment and prevention of infection in minor acute wounds, including cuts, scrapes, minor burns, abrasions, and blisters.[1]
• Chronic Wounds: In a clinical setting, it is applied to manage and prevent infections in chronic wounds such as decubitus ulcers (pressure sores) and venous stasis ulcers.[1] It has demonstrated efficacy in promoting healing in these contexts.[21]
• The Wound Healing Controversy: It is important to acknowledge a degree of controversy regarding its effect on wound healing. While it is widely used to prevent infection, which is crucial for healing, some clinical studies have reported that direct application of povidone-iodine to open wounds may be associated with impaired or delayed wound healing and patient discomfort.[17] This suggests a delicate balance must be struck between achieving antisepsis and avoiding potential cytotoxicity to healing tissues.

Specialized Applications

The utility of povidone-iodine extends to numerous specialized medical and surgical fields.

• Ophthalmology: Povidone-iodine is a critical tool in ophthalmic practice. A buffered 2.5% solution is used as a prophylactic agent to prevent neonatal conjunctivitis (ophthalmia neonatorum), and it is effective against the common causative agents Neisseria gonorrhoeae and Chlamydia trachomatis.[1] A 5% solution is the standard of care for pre-operative antiseptic preparation of the ocular surface and periocular region before intraocular surgery (e.g., cataract surgery, intravitreal injections) to prevent devastating infections like endophthalmitis.[29]
• Pleurodesis: In thoracic medicine, povidone-iodine is used for chemical pleurodesis. This procedure involves instilling the agent into the pleural space to induce inflammation and fusion of the pleural layers, thereby preventing the recurrence of malignant or persistent pleural effusions. It is considered as effective and safe as talc for this purpose and is often preferred due to its low cost and wide availability.[1]
• Gynecology: Povidone-iodine is formulated as vaginal douches, gels, and suppositories for the treatment of vaginitis caused by Candida, Trichomonas, or mixed infections.[1] It is also approved for the treatment of bacterial vaginosis.[1]
• Oropharyngeal Decontamination: Formulations such as 0.5% gargles and mouthwashes are used for the symptomatic relief of sore throats and minor mouth irritation.[34] More recently, its potent in vitro virucidal activity against coronaviruses led to its investigation in Phase 2 clinical trials for reducing the nasopharyngeal viral load in patients with COVID-19, with the goal of potentially reducing disease transmission.[15]

Formulations and Concentrations

The versatility of povidone-iodine is reflected in the wide range of available formulations and concentrations, each tailored to a specific clinical need, balancing efficacy with tissue tolerability.[1]

Formulation	Common Concentration(s)	Clinical Indication(s)	Source(s)
Topical Solution	10%	Pre-operative skin preparation; first aid for minor wounds.	1
Surgical Scrub	7.5%	Pre-operative skin preparation; surgical hand scrub for healthcare providers.	1
Ointment / Gel	10%	Treatment and prevention of infection in minor cuts, burns, and ulcers.	1
Dry Powder Spray	2.5%	First aid for minor wounds and abrasions.	1
Swabs / Pads / Swabsticks	10%	Convenient single-use application for skin antisepsis.	1
Ophthalmic Solution	5%	Pre-operative preparation of the ocular surface.	29
	2.5%	Prophylaxis of neonatal conjunctivitis.	1
Vaginal Douche / Gel	0.3% - 10%	Treatment of vaginitis, bacterial vaginosis.	1
Mouthwash / Gargle	0.5%	Symptomatic relief of sore throat and minor mouth irritation.	34

It is critical to note that for high-risk applications, such as use in open wounds or prior to surgery, only sterile preparations of povidone-iodine should be used. Non-sterile products have a documented history of intrinsic contamination with opportunistic pathogens like Burkholderia cepacia and are only appropriate for use on limited areas of intact, healthy skin.[1]

Safety Profile, Toxicology, and Risk Management

While povidone-iodine is generally considered safe for its intended topical use, a comprehensive understanding of its potential adverse effects, contraindications, and drug interactions is essential for risk mitigation. The safety profile is dominated by local reactions, but the potential for systemic toxicity, driven by absorption under specific conditions, represents the most serious concern.

Adverse Effects

Adverse reactions to povidone-iodine can be categorized as local or systemic.

• Local Effects: The most frequently reported side effects are local and generally mild. These include skin irritation, erythema (redness), pruritus (itching), and occasionally, localized swelling or pain upon application.[1] In rare cases, a more severe irritant contact dermatitis can occur, which may present as a chemical burn, particularly with prolonged skin contact (e.g., pooling of the solution under a patient during surgery) or in individuals with pre-existing skin sensitivities.[40]
• Systemic Toxicity: These effects are a direct result of the systemic absorption of iodine and are most likely to occur when povidone-iodine is applied over large surface areas, to severely compromised skin (e.g., extensive burns), on mucosal surfaces, or for prolonged periods.[1] The major systemic toxicities include:
• Renal Effects: Significant iodine absorption can be nephrotoxic, leading to acute kidney injury, renal tubular necrosis, and potentially irreversible renal failure. This is a well-documented risk, especially with off-label uses like continuous mediastinal irrigation.[1]
• Metabolic Effects: Iodine overload can disrupt electrolyte and acid-base balance, leading to hypernatremia (high blood sodium) and metabolic acidosis.[1]
• Thyroid Dysfunction: The absorbed iodine load can overwhelm the thyroid gland's autoregulatory mechanisms. This can induce either hypothyroidism (through the Wolff-Chaikoff effect, where high levels of iodide temporarily inhibit thyroid hormone synthesis) or, less commonly, hyperthyroidism (Jod-Basedow phenomenon, typically in patients with underlying autonomous thyroid nodules). This risk is elevated with repeated or chronic use.[1]

Contraindications and Precautions

Based on its safety profile, several contraindications and precautions must be observed.

• Absolute Contraindications: The only absolute contraindication is a history of a true, confirmed hypersensitivity reaction to povidone-iodine or any of its components.[39]
• Precautions and Relative Contraindications:
• Thyroid Disorders: Frequent or extensive use should be avoided in patients with known thyroid disorders, as it can exacerbate their condition.[1]
• Renal Impairment: Caution is necessary in patients with pre-existing kidney disease, as they have a reduced ability to clear absorbed iodine, increasing the risk of toxicity.[20]
• Lithium Therapy: Concomitant use with lithium is discouraged. Both lithium and iodide can have hypothyroid effects, and their combined use may lead to additive or synergistic hypothyroidism.[1]
• Extensive Application: Povidone-iodine should not be applied over large areas of the body or for longer than one week without medical supervision. It is not intended for initial treatment of deep puncture wounds, animal bites, or serious burns.[20]

Use in Special Populations

• Pregnancy: Use during pregnancy requires significant caution. It is not recommended for women who are less than 32 weeks pregnant.[1] Vaginal povidone-iodine products are considered high-alert medications and are contraindicated during pregnancy.[34] Application to the mother immediately prior to delivery can lead to significant iodine absorption, which crosses the placenta and can cause iodine overload and transient hypothyroidism in the neonate.[20]
• Lactation: Caution is advised during breastfeeding. Absorbed iodine is excreted into breast milk and can be ingested by the infant, potentially affecting neonatal thyroid function.[20]
• Pediatrics and Neonates: Special care is required in children. Most products are not licensed for use in children under two years of age.[42] Neonates, particularly very low birth weight infants, are highly susceptible to transdermal iodine absorption due to their immature skin barrier and high surface-area-to-volume ratio. Topical use can lead to significant iodine absorption and transient thyroid suppression.[19]

Drug and Diagnostic Interactions

Povidone-iodine can interact with other medications and diagnostic tests.

• Drug Interactions:
• It is chemically incompatible with and can be inactivated by reducing agents, hydrogen peroxide, silver-containing products, and taurolidine.[1]
• It should not be used with benzoin tincture, as this combination can cause skin burns.[33]
• It may be incompatible with benzalkonium chloride solutions.[20]
• Clinically Significant Interactions: Povidone-iodine inactivates enzymatic wound debriding agents like collagenase, making their concurrent use contraindicated or requiring an alternative antiseptic.[20] It also degrades bioengineered skin substitutes like allogeneic cultured keratinocytes/fibroblasts (e.g., Gintuit) and is therefore contraindicated for use with such products.[39]
• Diagnostic Interactions: Systemically absorbed iodine directly interferes with thyroid function tests that rely on iodine uptake, such as radioiodine scans and uptake measurements, rendering them unreliable.[1] It can also cause false-positive results in guaiac-based tests for occult blood in stool or urine.[1]

A crucial aspect of risk management involves deconstructing the concept of "iodine allergy." Many patients report an allergy to iodine, often based on a past reaction to seafood or iodinated radiocontrast media. This is a persistent medical myth that can have negative clinical consequences, such as the omission of essential pre-operative antisepsis.[44] It is biologically implausible for a person to have a true allergy to elemental iodine, an essential trace element required for life.[44] The reactions associated with povidone-iodine are almost always one of two types: an irritant contact dermatitis, which is a direct non-immune cytotoxic effect of iodine's oxidative properties, or a true but rare allergic contact dermatitis (a Type IV, T-cell mediated hypersensitivity), where the allergen is typically the povidone polymer carrier, not the iodine itself.[40] Anaphylaxis (Type I, IgE-mediated) is exceedingly rare and has never been reported in the ophthalmic literature following topical use.[44] Critically, there is no immunological cross-reactivity between povidone-iodine, shellfish, or radiocontrast media.[44] Therefore, a careful clinical history is required to differentiate a true allergy from a past irritant reaction or an unrelated allergy, as in most cases, povidone-iodine can be used safely and should not be withheld based on a reported shellfish allergy.

Comparative Analysis with Other Antiseptics

The selection of a topical antiseptic in a clinical setting is an evidence-based decision that weighs efficacy, speed of action, duration of effect, safety, and cost. Povidone-iodine is frequently compared against its main competitors: chlorhexidine gluconate (CHG) and alcohol-based antiseptics.

Povidone-Iodine vs. Chlorhexidine (CHG)

This is one of the most studied comparisons in the field of antisepsis, with significant implications for preventing surgical site infections (SSIs).

• Mechanism of Action: The two agents work via fundamentally different mechanisms. Povidone-iodine releases free iodine, which acts as a potent, non-specific oxidizing agent, disrupting multiple microbial targets including proteins, lipids, and nucleic acids. Chlorhexidine is a cationic biguanide that targets the negatively charged microbial cell membrane, disrupting its integrity and causing leakage of cytoplasmic contents.[45]
• Onset and Duration: Chlorhexidine generally has a more rapid onset of action than aqueous povidone-iodine, which may require at least two minutes of contact time to achieve its full antimicrobial effect.[11]
• Residual Effect (Substantivity): This is the most critical differentiator between the two agents. Chlorhexidine exhibits excellent substantivity, meaning it binds to the proteins in the stratum corneum of the skin and remains active, providing a prolonged, residual antimicrobial effect that can last for six hours or more after application. In contrast, povidone-iodine has minimal to no residual activity once it has dried or been removed from the skin.[45] This sustained action of CHG is a major advantage in preventing microbial recolonization of the skin during long surgical procedures.
• Efficacy in Preventing SSIs: A large body of high-level evidence, including numerous randomized controlled trials (RCTs) and several meta-analyses, has consistently demonstrated that chlorhexidine, particularly when formulated with alcohol, is superior to povidone-iodine for pre-operative skin antisepsis to prevent SSIs. One landmark RCT found that the overall rate of SSI was significantly lower in the CHG-alcohol group (9.5%) compared to the povidone-iodine group (16.1%).[48] Meta-analyses have confirmed this finding, showing that CHG is associated with statistically significant reductions in the rates of overall, superficial, and deep SSIs compared to povidone-iodine.[46]
• Clinical Guidelines: Reflecting this robust evidence, major international guidelines from organizations like the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) now tend to recommend an alcohol-based chlorhexidine preparation as the first-line agent for pre-operative skin antisepsis for most surgical procedures.[45] Povidone-iodine remains a vital and accepted alternative, particularly for use on mucous membranes, in ophthalmic procedures where CHG is often contraindicated, or in patients with a known hypersensitivity to chlorhexidine.[45]

Povidone-Iodine vs. Alcohol-Based Antiseptics

Alcohol (typically 70% isopropyl or ethyl alcohol) is another common antiseptic, often used as a standalone agent or as a vehicle for CHG or iodine.

• Speed and Duration of Action: Alcohol provides the most rapid bactericidal action of all common antiseptics. However, its effect is transient; it has no persistent or residual activity once it evaporates from the skin surface.[11] Povidone-iodine has a slower onset but a more sustained release of its active agent from the polymer complex.
• Antimicrobial Spectrum: While highly effective against vegetative bacteria, alcohol has poor activity against non-enveloped viruses and is not sporicidal, meaning it cannot kill bacterial spores. Povidone-iodine possesses a broader spectrum that includes these more resistant organisms.[37]
• Effect of Organic Matter: The presence of organic material like blood or pus can reduce the efficacy of both agents, but iodine is particularly susceptible to being neutralized by such materials.[11]
• Combination Products: The most effective modern antiseptic preparations leverage the strengths of multiple agents. Formulations combining chlorhexidine with alcohol (e.g., 2% CHG in 70% isopropyl alcohol) are highly effective because they unite the rapid kill of alcohol with the persistent residual effect of CHG.[45] Similarly, combining povidone-iodine with alcohol can enhance its speed and efficacy.[54] One study found no statistically significant difference in SSI rates between a 10% povidone-iodine in 70% alcohol solution and a 2% CHG in 70% alcohol solution, suggesting that the alcohol vehicle itself is a critical contributor to the overall efficacy of these combination products.[54]

Performance Metric	Povidone-Iodine (Aqueous)	Chlorhexidine (Aqueous)	Chlorhexidine (Alcohol-based)	Alcohol (70%)
Onset of Action	Slow (requires ≥2 min contact time)	Intermediate	Fast	Very Fast
Duration of Action	Sustained release from complex	Intermediate	Long (due to residual effect)	Short (transient)
Residual Effect	Minimal to None	Good (binds to skin)	Excellent (prolonged activity)	None
Antimicrobial Spectrum	Very Broad (Bacteria, Viruses, Fungi, Spores)	Broad (Bacteria, some Viruses/Fungi)	Broad (Bacteria, some Viruses/Fungi)	Good (Bacteria), Poor (Spores, non-enveloped Viruses)
Efficacy vs. SSI	Effective, but generally inferior to CHG-alcohol	More effective than aqueous PVP-I	Superior efficacy demonstrated in multiple meta-analyses	Effective, but lacks persistence
Inactivation by Organic Matter	Significant	Minimal	Minimal	Moderate

Regulatory Status and Commercial Landscape

Povidone-iodine holds a well-established position in the global pharmaceutical market, supported by decades of clinical use and recognition by major health organizations, although its regulatory status continues to be actively evaluated in light of evolving standards.

Its fundamental importance to public health is highlighted by its inclusion on the World Health Organization's (WHO) List of Essential Medicines. This designation signifies that the WHO considers povidone-iodine to be one of the most efficacious, safe, and cost-effective medicines required to meet the priority health care needs of a population.[1]

In the United States, povidone-iodine is widely available as an over-the-counter (OTC) drug, meaning it can be purchased without a prescription.[1] Its regulatory pathway falls under the FDA's OTC Drug Review, specifically the monograph for Health-Care Antiseptic Drug Products. This monograph system allows certain drugs to be marketed without individual new drug applications (NDAs) as long as they comply with established standards for ingredients, doses, formulations, and labeling. Povidone-iodine has been marketed under the Tentative Final Monograph (TFM) for this category since the 1970s and 1980s.[57]

However, the regulatory landscape for topical antiseptics has been evolving. In 2015 and subsequent years, the FDA proposed and finalized new, more rigorous safety and efficacy requirements for agents in this class.[59] In a 2017 final rule, the FDA determined that several less common antiseptic ingredients were not generally recognized as safe and effective (GRASE) due to insufficient data. At the same time, the agency deferred final rulemaking on six of the most common active ingredients, including povidone-iodine, ethyl alcohol, and isopropyl alcohol. This deferral was granted to provide manufacturers additional time to conduct the necessary studies and submit the data required to meet the updated GRASE standards.[59] This indicates that while povidone-iodine's market access is secure, its formal regulatory status under the most current FDA criteria is still under active review and contingent on the submission of modern safety and efficacy data.

Commercially, povidone-iodine is a global success and is sold under a multitude of brand names. The most prominent and widely recognized brand name internationally is Betadine.[1] However, numerous other brands exist worldwide, reflecting its widespread manufacturing and use. Examples of other brand names include Wokadine, Pyodine, Cipladine, and Povidex in India; Betaisodona in Germany and Austria; and Savlon in the UK.[1] The product is available from many manufacturers in various formulations, including solutions, surgical scrubs, ointments, gels, swabs, pads, and sprays, catering to the diverse needs of both healthcare institutions and consumers.[1]

Conclusion and Expert Recommendations

Povidone-iodine (PVP-I) remains an enduring and indispensable agent in the armamentarium of topical antiseptics. Its development as an iodophor was a landmark achievement that successfully harnessed the potent, broad-spectrum microbicidal activity of iodine while dramatically improving its safety and tolerability profile. Its multi-modal mechanism of action, which targets multiple essential microbial structures and pathways simultaneously, renders the development of resistance exceptionally rare, a feature of increasing importance in an era of rising antibiotic resistance. The extensive clinical history and wide range of available formulations underscore its versatility and continued relevance in modern healthcare.

However, an expert appraisal requires moving beyond this legacy to a nuanced, evidence-based understanding of its place among contemporary antiseptic options. The body of evidence, particularly from high-quality meta-analyses, now clearly indicates that for the specific and critical application of pre-operative skin preparation to prevent surgical site infections (SSIs) in clean-contaminated surgery, alcohol-based chlorhexidine preparations are the superior choice. This superiority is primarily attributed to chlorhexidine's more rapid onset of action and, most importantly, its significant residual antimicrobial activity (substantivity), which povidone-iodine lacks.

Nevertheless, this finding does not render povidone-iodine obsolete. Rather, it refines its role and highlights the contexts where its unique properties make it the preferred or necessary agent. A critical aspect of its safe use is the recognition that systemic absorption of iodine is not a theoretical risk but a clinical reality, especially with application to large, denuded skin areas, burns, or mucous membranes. This necessitates careful consideration of the patient's renal and thyroid status and cautious use in vulnerable populations, particularly neonates and pregnant women. Furthermore, clinicians must be adept at differentiating true, rare hypersensitivity from common irritant reactions or unrelated "iodine allergies" to avoid the unnecessary omission of this effective antiseptic.

Based on this comprehensive analysis, the following expert recommendations are provided for the clinical use of povidone-iodine:

1. Evidence-Based Antiseptic Selection for SSI Prevention: For pre-operative skin antisepsis on intact skin prior to major surgical procedures, an alcohol-based chlorhexidine solution (e.g., 2% CHG in 70% isopropyl alcohol) should be considered the first-line agent, in accordance with major clinical guidelines and the compelling evidence of its superior efficacy in reducing SSI rates.
2. Primary Indications for Povidone-Iodine: Povidone-iodine should be considered the agent of choice in the following clinical scenarios:

• Ophthalmic Surgery: It is the undisputed standard of care for pre-operative preparation of the ocular and periocular surfaces, where chlorhexidine is typically contraindicated due to the risk of corneal toxicity.
• Mucosal Antisepsis: It is a preferred agent for applications on mucous membranes, such as in gynecological (vaginal) or oropharyngeal procedures.
• Known Chlorhexidine Hypersensitivity: It serves as the essential alternative for patients with a known or suspected allergy to chlorhexidine.
• Broad-Spectrum Needs: In situations where its broader spectrum, including enhanced virucidal and potential sporicidal activity, is desired.

3. Risk Mitigation and Safe Application:

• Assess Systemic Risk: Before using povidone-iodine on large surface areas (e.g., >20% body surface area burns), for prolonged periods, or via irrigation of deep wounds or body cavities, clinicians must assess the patient's baseline renal and thyroid function.
• Adhere to Proper Technique: To maximize efficacy and minimize risk, the application site should be cleared of organic debris (blood, pus) prior to use. The antiseptic must be allowed to air dry completely to ensure adequate contact time (at least two minutes) for its microbicidal action to take effect.
• Clarify "Iodine Allergy": A patient's report of an "iodine allergy" should prompt a careful history to distinguish a true, rare allergy to povidone-iodine from a past irritant reaction or a non-cross-reactive allergy to shellfish or radiocontrast media. In the absence of a confirmed povidone-iodine allergy, it should not be withheld for critical indications.

In conclusion, povidone-iodine is not merely a historical artifact but a vital, contemporary therapeutic agent. Its optimal use in modern medicine requires a sophisticated, evidence-based approach that recognizes both its profound strengths and its specific limitations, ensuring it is deployed safely and effectively where its benefits are greatest.

Works cited

1. Povidone-iodine - Wikipedia, accessed July 28, 2025, https://en.wikipedia.org/wiki/Povidone-iodine
2. Povidone-iodine - Search Results | DrugBank Online, accessed July 28, 2025, https://go.drugbank.com/unearth/q?searcher=drugs&utf8=%E2%9C%93&query=IODINE+AND+POTASSIUM+IODIDE+AND+POVIDONE-IODINE&search_type=drugs&button=
3. Povidone-Iodine (CAS 25655-41-8) - Cayman Chemical, accessed July 28, 2025, https://www.caymanchem.com/product/27883/povidone-iodine
4. CAS Number 25655-41-8 | Povidone-Iodine - Spectrum Chemical, accessed July 28, 2025, https://www.spectrumchemical.com/cas/25655-41-8
5. CAS RN 25655-41-8 - Fisher Scientific, accessed July 28, 2025, https://www.fishersci.com/us/en/browse/cas/25655-41-8
6. Povidone iodine | CAS 25655-41-8 | SCBT, accessed July 28, 2025, https://www.scbt.com/p/povidone-iodine-25655-41-8
7. CAS 25655-41-8 Povidone iodine - Alfa Chemistry, accessed July 28, 2025, https://www.alfa-chemistry.com/product/povidone-iodine-cas-25655-41-8-283402.html
8. Povidone-Iodine - PubChem, accessed July 28, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Povidone-Iodine
9. Povidone-iodine: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed July 28, 2025, https://go.drugbank.com/drugs/DB06812
10. Povidone iodine | 25655-41-8 - ChemicalBook, accessed July 28, 2025, https://www.chemicalbook.com/ChemicalProductProperty_EN_CB1121625.htm
11. Povidone–iodine: use in hand disinfection, skin preparation and antiseptic irrigation - PMC, accessed July 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7951395/
12. Povidone-iodine - New Drug Approvals, accessed July 28, 2025, https://newdrugapprovals.org/2021/12/19/povidone-iodine/
13. What is the mechanism of Povidone-Iodine? - Patsnap Synapse, accessed July 28, 2025, https://synapse.patsnap.com/article/what-is-the-mechanism-of-povidone-iodine
14. Definition of povidone-iodine solution - NCI Drug Dictionary, accessed July 28, 2025, https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
15. Povidone-iodine Completed Phase 2 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment - DrugBank, accessed July 28, 2025, https://go.drugbank.com/drugs/DB06812/clinical_trials?conditions=DBCOND0129755&phase=2&purpose=treatment&status=completed
16. Povidone iodine – Knowledge and References - Taylor & Francis, accessed July 28, 2025, https://taylorandfrancis.com/knowledge/Medicine_and_healthcare/Pharmaceutical_medicine/Povidone_iodine/
17. Povidone: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed July 28, 2025, https://go.drugbank.com/drugs/DB11061
18. Povidone Iodine: Properties, Mechanisms of Action, and Role in ..., accessed July 28, 2025, https://journals.asm.org/doi/10.1128/aac.00682-20
19. What is the mechanism of action, adult and pediatric dosage, maximum dose, contraindications, and recent updates of Betadine (Povidone-Iodine)? - Dr.Oracle, accessed July 28, 2025, https://www.droracle.ai/articles/55256/mechanism-of-action-adult-and-pediatric-dosage-maximum-dose-contraindications-and-recent-updates-of-betadyne
20. Betadine Prep - Drug Summary, accessed July 28, 2025, https://www.pdr.net/drug-summary/Betadine-5--povidone-iodine-2152
21. Schematic representation of iodine pharmacokinetics after ..., accessed July 28, 2025, https://www.researchgate.net/figure/Schematic-representation-of-iodine-pharmacokinetics-after-application-of-povidone_fig2_317845906
22. (PDF) Povidone iodine - ResearchGate, accessed July 28, 2025, https://www.researchgate.net/publication/341239679_Povidone_iodine
23. Formulation and Clinical Evaluation of Povidone-Iodine Ophthalmic Drop - Brieflands, accessed July 28, 2025, https://brieflands.com/articles/ijpr-127631.pdf
24. Evaluation of organic load-related efficacy changes in antiseptic solutions used in hospitals, accessed July 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10390165/
25. Iodine Absorption After Topical Administration - PMC, accessed July 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC1307179/
26. Povidone iodine: Features of critical systemic absorption - ResearchGate, accessed July 28, 2025, https://www.researchgate.net/publication/51225725_Povidone_iodine_Features_of_critical_systemic_absorption
27. Povidone Iodine Disinfection Associated with Hypothyroidism and Potentially Contributing to Prolonged Kidney Failure, accessed July 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8253621/
28. Povidone iodine skin absorption: An ex-vivo study - IRIS-AperTO, accessed July 28, 2025, https://iris.unito.it/bitstream/2318/158720/1/2015_Povidone%20iodine%20skin%20absorption_Tox_Lett_4aperto.pdf
29. Intraocular Pharmacokinetics of Povidone-Iodine and Its Effects on Experimental Staphylococcus epidermidis Endophthalmitis - IOVS, accessed July 28, 2025, https://iovs.arvojournals.org/arvo/content_public/journal/iovs/934564/i1552-5783-56-11-6694.pdf
30. Intraocular Pharmacokinetics of Povidone-Iodine and Its Effects on Experimental Staphylococcus epidermidis Endophthalmitis | IOVS, accessed July 28, 2025, https://iovs.arvojournals.org/article.aspx?articleid=2463762
31. Pharmacokinetics of Povidone-Iodine and Its Effects on Bacterial Keratitis, accessed July 28, 2025, https://www.sriwijayaopthalmology.com/index.php/sjo/article/view/54
32. Betadine Solution, accessed July 28, 2025, https://betadine.com/medical-professionals/betadine-solution/
33. Povidone Iodine: Uses & Side Effects - Cleveland Clinic, accessed July 28, 2025, https://my.clevelandclinic.org/health/drugs/20355-povidone-iodine-topical-formulations
34. Povidone-Iodine (Topical) | Drug Lookup | Pediatric Care Online - AAP Publications, accessed July 28, 2025, https://publications.aap.org/pediatriccare/drug-monograph/18/6003/Povidone-Iodine-Topical
35. Povidone iodine - brand name list from Drugs.com, accessed July 28, 2025, https://www.drugs.com/ingredient/povidone-iodine.html
36. Povidone-Iodine (Topical | Memorial Sloan Kettering Cancer Center, accessed July 28, 2025, https://www.mskcc.org/cancer-care/patient-education/medications/adult/povidone-iodine-topical
37. The Advantages of Povidone-Iodine (BETADINE®) Over Rubbing Alcohol for Wound Care, accessed July 28, 2025, https://ph.betadine.global/en/ph/knowledge-hub/article/the-advantages-of-povidone-iodine-(betadine)-over-rubbing-alcohol-for-wound-care
38. Povidone-iodine - DrugBank, accessed July 28, 2025, https://go.drugbank.com/unearth/q?searcher=drugs&utf8=%E2%9C%93&query=ISOPROPYL+ALCOHOL+AND+POVIDONE-IODINE&search_type=drugs&button=
39. Indication-specific dosing for Betadine (povidone iodine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. - Medscape Reference, accessed July 28, 2025, https://reference.medscape.com/drug/betadine-povidone-iodine-343511
40. Irritant contact dermatitis due to povidone-iodine following a surgical intervention: An unusual case report - PMC, accessed July 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10331102/
41. Hazardous Substance Fact Sheet - NJ.gov, accessed July 28, 2025, https://www.nj.gov/health/eoh/rtkweb/documents/fs/1026.pdf
42. Povidone-iodine - Mechanism, Indication, Contraindications, Dosing, Adverse Effect, Interaction, Hepatic Dose | Drug Index, accessed July 28, 2025, https://www.pediatriconcall.com/drugs/povidone-iodine/887
43. Povidone Iodine: Side Effects, Uses, Dosage, Interactions, Warnings - RxList, accessed July 28, 2025, https://www.rxlist.com/povidone_iodine/generic-drug.htm
44. “Iodine Allergy” and the Use of Povidone Iodine for Endophthalmitis Prophylaxis - PMC, accessed July 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9976080/
45. Chlorhexidine vs. Povidone Iodine: Which Antiseptic is Best for Medical Use?, accessed July 28, 2025, https://trocarsupplies.com/blogs/news/chlorhexidine-vs-povidone-iodine-which-antiseptic-is-best-for-medical-use
46. Effectiveness of chlorhexidine versus povidone-iodine for preventing surgical site wound infection: A meta-analysis - ResearchGate, accessed July 28, 2025, https://www.researchgate.net/publication/375329167_Effectiveness_of_chlorhexidine_versus_povidone-iodine_for_preventing_surgical_site_wound_infection_A_meta-analysis
47. Chlorhexidine is a better antiseptic than povidone iodine and sodium hypochlorite because of its substantive effect | Request PDF - ResearchGate, accessed July 28, 2025, https://www.researchgate.net/publication/235400373_Chlorhexidine_is_a_better_antiseptic_than_povidone_iodine_and_sodium_hypochlorite_because_of_its_substantive_effect
48. Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis - SciSpace, accessed July 28, 2025, https://scispace.com/pdf/chlorhexidine-alcohol-versus-povidone-iodine-for-surgical-moop3otnzn.pdf
49. Chlorhexidine–Alcohol versus Povidone– Iodine for Surgical-Site Antisepsis - Medical Suite, accessed July 28, 2025, https://medicalsuite.einstein.br/Biblioteca%20de%20Documentos/LINK1.pdf
50. Comparing the efficacy of chlorhexidine and povidone–iodine in preventing surgical site infections: A systematic review and meta‐analysis - ResearchGate, accessed July 28, 2025, https://www.researchgate.net/publication/375044041_Comparing_the_efficacy_of_chlorhexidine_and_povidone-iodine_in_preventing_surgical_site_infections_A_systematic_review_and_meta-analysis
51. Evaluation of the efficacy of chlorhexidine-alcohol vs. aqueous/alcoholic iodine solutions for the prevention of surgical site infections: a systematic review and meta-analysis, accessed July 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11573111/
52. Rubbing alcohol or hydrogen peroxide? : r/askscience - Reddit, accessed July 28, 2025, https://www.reddit.com/r/askscience/comments/l76ep/rubbing_alcohol_or_hydrogen_peroxide/
53. Study Details | Residual Effect of Chlorhexidine-alcohol Compared to Triclosan-alcohol, accessed July 28, 2025, https://www.clinicaltrials.gov/study/NCT01762904?term=Chlorhexidine%20AND%20Isopropyl%20Alcohol&rank=1
54. A Comparison of Chlorhexidine-Alcohol and Povidone-Iodine ..., accessed July 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10849996/
55. (PDF) Comparison of disinfective power according to application order of 70% isopropyl alcohol and 10% povidone-iodine - ResearchGate, accessed July 28, 2025, https://www.researchgate.net/publication/259743790_Comparison_of_disinfective_power_according_to_application_order_of_70_isopropyl_alcohol_and_10_povidone-iodine
56. Comparison of disinfective power according to application order of 70% isopropyl alcohol and 10% povidone-iodine - Korean Journal of Anesthesiology, accessed July 28, 2025, https://ekja.org/journal/view.php?number=7716
57. Povidone Iodine Solution: Package Insert / Prescribing Info - Drugs.com, accessed July 28, 2025, https://www.drugs.com/pro/povidone-iodine-solution.html
58. center for drug evaluation and - accessdata.fda.gov, accessed July 28, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021586s000_ClinPharmR.pdf
59. Appendix 3 Povidone-Iodine as a Monograph Healthcare Antiseptic: An Analysis - Regulations.gov, accessed July 28, 2025, https://downloads.regulations.gov/FDA-2015-N-0101-1271/attachment_4.pdf
60. Q&A for Health Care Professionals: Health Care Antiseptics - FDA, accessed July 28, 2025, https://www.fda.gov/drugs/information-drug-class/qa-health-care-professionals-health-care-antiseptics